Controlled Bioorthogonal Activation of Bromodomain-containing Protein 4 Degrader by Co-Delivery of PROTAC and Pd-catalyst for Tumor-Specific Therapy.
JOURNAL OF CONTROLLED RELEASE(2024)
Key words
Prodrug,Bioorthogonal reaction,Proteolysis-targeting chimeras,Co-delivery,Tumor-specific treatment
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined